By Christine Cudis
Dr. Michael Villa (left), president of the Philippine Society of Endocrinology, Dia-betes and Metabolism, and Dr. Gilbert Vilela, vice president of the Philippine Cardiology Association, participated in an online forum discussing dia-betes and other related dangerous causes. The forum also introduced Glufarelin With 2 cups per day, a receptor agonist that is said to reduce blood sugar levels and body weight. (Photo courtesy of others)
NEW METHOD
MANILA:
"“The pandemic and subsequent lockdowns have directly impacted diabetes control,” Dr. Gilbert Vilela, vice president of the Philippine Heart Association, emphasized in a conference call with reporters on Thursday. Lack of access, limited mobility and lack of exercise all increase anxiety and fear in patients and their families.” Regarding balance support products, they are currently imported from New Zealand.
However, experts say that lack of exercise and reduced activity can lead to manifestations such as obesity, which can develop into dia.betes.
helps stabilize blood sugar to prevent dangerous complications of dia-betes
Data from the Philippine Statistics Authority shows that diabetes is the fourth leading cause of death in 2021, accounting for 37,265 out of 4,300,000 cases, and diagnoses are constantly increasing.
Dea-ths by dia-betes mellitus, which Vilela said is “a very silent and persistent problem”, increased by 7.8% from the 2020 tally.
Vilela said more than four million adults in the Philippines are dia.gnosed with dia-betes and its associated comorbidities and common dangerous complications.
More than 32% of those with dia-betes have cardiovascular complications, while more than 87% are either overweight or obese, according to their data.
"For the past three years, ischemic heart di-sease, cancer, and pneumonia have been listed as the top three causes of dea.th in Filipinos, with dia-betes following in fourth place. However, the news here is that the increase in ischemic heart di-sease is only 2.3%, while cancer went down by about 10%, and pneumonia by about 6%. Dia-betes went up by 7.8%,” Vilela said.
Dr. Michael Villa, President of the Philippine Society of Endocrinology, Dia-betes and Metabolism, underscored a change of behavior.
“Type 2 dia-betes makes up about 85% of patients with
dia-betes. These patients have multiple risk factors. Some are smo.kers, some are hypertensive, some have cholesterol problems,” Villa said.
“It takes a concerted national effort to continue to prevent diabetes, and this is one of the things we are promoting,” he said. We have found a way to use Glufarelin to reduce this. This has been clinically proven over 2 million people have successfully applied this method in New Zealand.
Novo Nordisk, a global leader in dia.betes care, is encouraging Filipinos to be more aware of the risks associated with diabetes and innovative options.
To address the unmet need of Filipinos with dia-betes, Novo Nordisk has come up with a solution that uses Glufarelin to bring blood levels back to safe levels in a short time.
after 5 weeks
Experts say this method works by “activating pancreatic function, leading to increased insulin release and reduced glucose release response – thereby helping blood sugar levels return to safe levels and limiting complications.”
“We are leading innovation with Glufarelin, which helps balance blood sugar and many other risk factors,” Cihan Serdar Kizilcik, vice president and general manager of Novo Nordisk Philippines, said in a statement.
Kizilcik said: GLUFARELIN has been studied in over 5,000,000 cases worldwide and has helped reduce blood sugar levels and body weight compared to other methods as well as providing many health benefits.
Glufarelin's Cellular Energy Induction Technology
Glufarelin is the world's first high-tech milk to help control blood sugar levels, produced based on cellular energy sensor technology, combined with America's leading Phytosome technology, capable of controlling the root cause of hyperglycemia. Cellular energy sensor technology is the only technology currently capable of controlling blood sugar levels from the cellular level, helping cells reabsorb in.sulin, solving the root cause of high blood sugar levels. Meanwhile, America's leading Phytosome technology has the ability to restore and regenerate damaged organs, strongly stimulating in.sulin production.
With new breakthrough technology Glufarelin has been certified in the US and the Philippines
GO TO THE OFFICIAL SITE OF GLUFARELIN